Farmacia
Faculty
Hospital Clinic Barcelona
Barcelona, EspañaPublications in collaboration with researchers from Hospital Clinic Barcelona (114)
2024
-
In vitro activity of ozenoxacin against Staphylococcus aureus and Streptococcus pyogenes clinical isolates recovered in a worldwide multicentre study (2020-2022)
JAC-Antimicrobial Resistance, Vol. 6, Núm. 3
-
Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteraemic urinary tract infections: a post-hoc analysis of a multicentre prospective cohort in Spain
Journal of Hospital Infection, Vol. 151, pp. 173-185
-
Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in Spain
HIV Medicine
-
Treatment adherence to oral chemotherapy in patients with locally advanced or metastatic non-small cell lung cancer: Protocol for a hospital pharmacy-based real-world study
Farmacia Hospitalaria
2023
-
Antimicrobial resistance in Gram-negative bacilli in Spain: an experts’ view
Revista Espanola de Quimioterapia, Vol. 36, Núm. 1, pp. 65-81
-
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)
Leukemia
-
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
Leukemia, Vol. 37, Núm. 2, pp. 339-347
-
Drug-related problems as reason for emergency department visit: 3 years of the FARM-URG registry
International Journal of Pharmacy Practice, Vol. 31, Núm. 4, pp. 417-422
-
Elafibranor upregulates the EMT-inducer S100A4 via PPARβ/δ
Biomedicine and Pharmacotherapy, Vol. 167
-
Map of use of parenteral analgesic admixtures in Spain. MEDPAIN project
Farmacia Hospitalaria, Vol. 47, Núm. 4, pp. 161-167
-
Pharmacokinetics, the Immunological Impact, and the Effect on HIV Ex-Vivo Infectivity of Maraviroc, Raltegravir, and Lopinavir in Men Who Have Sex with Men Using Postexposure Prophylaxis
AIDS Research and Human Retroviruses
-
Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)
The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2291-2296
-
The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)
Frontiers in Microbiology, Vol. 14
2022
-
Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma
Matrix Biology, Vol. 111, pp. 207-225
-
Imipenem-Relebactam Susceptibility in Enterobacterales Isolates Recovered from ICU Patients from Spain and Portugal (SUPERIOR and STEP Studies)
Microbiology spectrum, Vol. 10, Núm. 5, pp. e0292722
-
In Vitro Activity of Cefepime-Taniborbactam against Carbapenemase-Producing Enterobacterales and Pseudomonas aeruginosa Isolates Recovered in Spain
Antimicrobial Agents and Chemotherapy, Vol. 66, Núm. 3
-
In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies)
The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 11, pp. 3163-3172
-
Location, morphology and invasiveness of lateral spreading tumors in the colorectum differ between two large cohorts from an eastern and western country
Gastroenterologia y Hepatologia, Vol. 45, Núm. 6, pp. 440-449
-
Patient Experience Evaluation of the CMO-Based Pharmaceutical Care Model vs Usual Care in People Living with HIV
Journal of Multidisciplinary Healthcare, Vol. 15, pp. 2991-3003
2021
-
A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?
Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2677-2699